Cercar
01/01/2026
EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis
Marzo-Ortega, H, Harrison, SR, Fragoulis, GE, Michelena, X, Macía-Villa, C, Aydin, SZ, Balanescu, A, Bertheussen, H, Bundy, C, Chimenti, MS, Gisondi, P, Glintborg, B, Gossec, L, Kalyoncu, U, Lubrano, E, Nagy, G, Wagenaar, W, Puig, L, Queiro, R, Rahman, P, Shumnalieva, R, Soriano, ER, van den Bosch, F, Sande, MMGHV, Sepriano, A, Machado, PM, Siebert, S. EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(1)DOI:10.1016/j.ard.2025.10.002. PMID:41168056. IF:20.600(Q1/1D).
01/12/2025
ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa
Grau-Pérez, M, Ciudad, C, Molina-Leyva, A, Martorell, A, Vilarrasa, E, Albert, I, Garcias-Ladaria, J, Melgosa, FJ, Rivera, R, Campos, M, Haselgruber, S, Ochando, G, Pascual, JC, García-Ruiz, R, Alfageme, F. ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. DERMATOLOGY. 2025; 241(5-6)DOI:10.1159/000546647. PMID:40587963. IF:2.700(Q2/4D).
01/12/2025
REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS
Ferrer, AL, Belinchón, I, Serra, MC, Clua, MG, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/12/2025
UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS
Ferrer, AL, Belinchón, I, Serra, MC, Martínez, LE, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/12/2025
HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS
Strober, B, Puig, L, Lebwohl, MG, Lakshminarasimhan, B, Khan, SA, Pillai, N, Kappelhoff, B, Weatherill, A, Warren, RB. HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).
01/11/2025
Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?
Fernández, CPH, Borrego, L, Arnau, AMG, Sánchez, TS, Carrillo, JMC, Ninet, VZ, Baldrich, ES, Miquel, FJM, Salvador, JFS, Guijarro, SC, Gilo, AS, García, PM, Triviño, FN, Romero, FT, Serna, MR, Ninot, GM, González, IR, de la Fuente, EG, Nieto, MAP, Guillén, PSP, Pérez, JS, Rodríguez, JJP, Ortega, MEG, Pérez, RG, Doval, IG, Descalzo, MAG. Should Hydroxyisohexyl 3-Cyclohexene Carboxaldehyde (Lyral®) still be part of the Baseline Series?. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2024.10.063. PMID:40024601. IF:(Q/D).
01/09/2025
Azathioprine for the Treatment of Chronic Spontaneous Urticaria Refractory to Antihistamines, Omalizumab, and Ciclosporin: A Case Series
Mateu-Arrom, L, Martin, R, Expósito-Serrano, V, Alvarez-Abella, A, Serra-Baldrich, E, Spertino, J. Azathioprine for the Treatment of Chronic Spontaneous Urticaria Refractory to Antihistamines, Omalizumab, and Ciclosporin: A Case Series. Actas Dermo-Sifiliograficas. 2025; 116(8)DOI:10.1016/j.ad.2025.05.022. PMID:40480489. IF:(Q/D).
01/09/2025
Similarity of efficacy of SB17 to reference ustekinumab for moderate-to-severe psoriasis through 12 weeks in different demographic and comorbidity subgroups
Feldman, SR, Sanz, LP, Girolomoni, G, Jo, SJ, Jung, H, Jung, J. Similarity of efficacy of SB17 to reference ustekinumab for moderate-to-severe psoriasis through 12 weeks in different demographic and comorbidity subgroups. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).
01/09/2025
Bimekizumab achievement of 'super response' using a previously published definition in moderate to severe plaque psoriasis: Results from four phase 3/3b trials
Lebwohl, M, Langley, RG, Strober, B, Thaçi, D, Armstrong, A, Gordon, KB, Puig, L, Davies, O, Peterson, L, Davis, L, Warren, RB. Bimekizumab achievement of 'super response' using a previously published definition in moderate to severe plaque psoriasis: Results from four phase 3/3b trials. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2025; 93(3)DOI:. PMID:. IF:11.800(Q1/1D).
01/07/2025
Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study
Ceravalls, J, Giménez-Arnau, AM, Exposito-Serrano, V, Chico, NF, Moya, AL, Bielsa, I, Ribó, P, Mascaró-Hereza, B, Bonfill-Orti, M, Spertino, J, Serra, E, Baliu-Piqué, C, Melé-Ninot, G. Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study. Actas Dermo-Sifiliograficas. 2025; 116(7)DOI:10.1016/j.ad.2024.08.014. PMID:. IF:(Q/D).
01/06/2025
Surgical Approach to Hidradenitis Suppurativa
Mateu-Arrom, L, Puig, L, Vilarrasa, E. Surgical Approach to Hidradenitis Suppurativa. Actas Dermo-Sifiliograficas. 2025; 116(6)DOI:10.1016/j.ad.2024.10.061. PMID:40185225. IF:(Q/D).
01/06/2025
Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods
Smith, A, Armstrong, AW, Elewski, B, Rich, P, Augustin, M, Carrascosa, JM, Vender, R, Lambert, J, Pinto, JML, Hoepken, B, Kavanagh, S, Puig, L. Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2025; 66DOI:. PMID:. IF:1.800(Q3/6D).
01/04/2025
Real-world Efficacy of Brodalumab in Patients with moderate to severe Plaque Psoriasis, in Patients with BMI>30 and BMI=30, BROACTIVE: 2-year Results
Escalas, J, Armesto, S, Abalde, T, Blanco, IR, Blanco, MR, Herrera-Acosta, E, Puig, L, Morales, AM, Ferrán-Farrés, M, Auhage, E, Ribera, M. Real-world Efficacy of Brodalumab in Patients with moderate to severe Plaque Psoriasis, in Patients with BMI>30 and BMI=30, BROACTIVE: 2-year Results. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/04/2025
Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis
Thaçi, D, Puig, L, Papp, K, Gold, LS, Fernández-Peñas, P, Huang, YH, Dossenbach, M, Falques, M, Agell, H, Schönherr, F, Vestergaard, C. Absolute EASI response achieved by lebrikizumab over 16 weeks in patients with moderate-to-severe atopic dermatitis. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2025; 23DOI:. PMID:. IF:3.800(Q1/2D).
01/01/2025
EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY
Ameen, A, Serra-Baldrich, E, Arm-Strong, A, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. EFFECTIVENESS OF 12-MONTHS TRALOKINUMAB TREATMENT IN 124 ADULTS WITH ATOPIC DERMATITIS WITH GENITAL INVOLVEMENT: FINAL REAL-WORLD DATA FROM THE PROSPECTIVE, NON-INTERVENTIONAL, INTERNATIONAL, SINGLE-COHORT TRACE STUDY. ACTA DERMATO-VENEREOLOGICA. 2025; 105DOI:. PMID:. IF:3.700(Q1/2D).
12/01/2024
Student survey after ten years of continuous blended teaching of echocardiography.
Parra VM, Fita G, Azqueta M, González M, Aranda F, Maestre M, Silva J, Hortal J, Morales D, Bórquez E, Adasme F, Real MI, Mercadal J, Zelada P, Riobó G, Galdames K, Domenech RJ. Student survey after ten years of continuous blended teaching of echocardiography.. Revista Espanola De Anestesiologia Y Reanimacion. 2024; 71(1)DOI:10.1016/j.redare.2023.05.004. PMID:37683971. IF:(Q/D).
01/12/2023
Prediction of Acute Myocardial Injury in Noncardiac Surgery in Patients at Risk for Major Adverse Cardiovascular and Cerebrovascular Events: A Multivariable Risk Model.
Mases A, Beltrán de Heredia S, Gallart L, Román L, Bosch L, Núñez M, Rueda M, Recasens L, Sabaté S. Prediction of Acute Myocardial Injury in Noncardiac Surgery in Patients at Risk for Major Adverse Cardiovascular and Cerebrovascular Events: A Multivariable Risk Model.. ANESTHESIA AND ANALGESIA. 2023; 137(6)DOI:10.1213/ANE.0000000000006469. PMID:37043386. IF:4.600(Q1/2D).
26/08/2023
Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).
Llau JV, Aldecoa C, Guasch E, Marco P, Marcos-Neira P, Paniagua P, Páramo JA, Quintana M, Rodríguez-Martorell FJ, Serrano A. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).. Revista Espanola De Anestesiologia Y Reanimacion. 2023; 70(7)DOI:10.1016/j.redare.2023.08.001. PMID:37640281. IF:(Q/D).
01/08/2023
Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).
Llau JV, Aldecoa C, Guasch E, Marco P, Marcos-Neira P, Paniagua P, Páramo JA, Quintana M, Rodríguez-Martorell FJ, Serrano A. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II).. Medicina Intensiva. 2023; 47(8)DOI:10.1016/j.medine.2023.03.019. PMID:37536911. IF:(Q/D).
01/07/2023
Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.
Castellarnau S, Gaya JM, Espinosa J, Sierra P, Huguet J, Palou J, Hernando D, Sabaté S, Breda A. Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.. Actas Urologicas Espanolas. 2023; 47(6)DOI:10.1016/j.acuroe.2023.01.006. PMID:36842706. IF:(Q/D).
01/06/2022
Intraoperative positive end-expiratory pressure and postoperative pulmonary complications: a patient-level meta-analysis of three randomised clinical trials.
Campos NS, Bluth T, Hemmes SNT, Librero J, Pozo N, Ferrando C, Ball L, Mazzinari G, Pelosi P, Gama de Abreu M, Schultz MJ, Serpa Neto A, Unzueta C., Moral M.V., Sabate, S, Cegarra V., PROVE Network. Intraoperative positive end-expiratory pressure and postoperative pulmonary complications: a patient-level meta-analysis of three randomised clinical trials.. BRITISH JOURNAL OF ANAESTHESIA. 2022; 128(6)DOI:10.1016/j.bja.2022.02.039. PMID:35431038. IF:9.800(Q1/1D).
01/04/2022
Higher Adherence to ERAS Society® Recommendations is Associated with Shorter Hospital Stay Without an Increase in Postoperative Complications or Readmissions in Bariatric Surgery: the Association Between Use of Enhanced Recovery After Surgery Protocols and Postoperative Complications after Bariatric Surgery (POWER 3) Multicenter Observational Study.
Ripollés-Melchor J, Sánchez-Santos R, Abad-Motos A, Gimeno-Moro AM, Díez-Remesal Y, Jove-Alborés P, Aragó-Chofre P, Ortiz-Sebastian S, Sánchez-Martín R, Ramírez-Rodríguez JM, Trullenque-Juan R, Valentí-Azcárate V, Ramiro-Ruiz Á, Correa-Chacón OC, Batalla A, Gimeno-Grauwinkel C, Sanahuja-Blasco JM, González-Valverde FM, Galán-Menéndez P, Díez-Zapirain MJ, Vilallonga R, Zorrilla-Vaca A, Pascual-Bellosta AM, Martínez-Ubieto J, Carrascosa-Mirón T, Ruiz-Escobar A, Martín-García-Almenta E, Suárez-de-la-Rica A, Bausili M, Palacios-Cordoba Á, Olvera-García MM, Meza-Vega JA, Sánchez-Pernaute A, Abad-Gurumeta A, Ferrando-Ortola C, Martín-Vaquerizo B, Torres-Alfonso JR, Aguado-Sánchez S, Sánchez-Cabezudo-Noguera F, García-Erce JA, Aldecoa C. Higher Adherence to ERAS Society® Recommendations is Associated with Shorter Hospital Stay Without an Increase in Postoperative Complications or Readmissions in Bariatric Surgery: the Association Between Use of Enhanced Recovery After Surgery Protocols and Postoperative Complications after Bariatric Surgery (POWER 3) Multicenter Observational Study.. OBESITY SURGERY. 2022; 32(4)DOI:10.1007/s11695-022-05949-6. PMID:35143011. IF:2.900(Q2/3D).
01/11/2021
Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study
Zorrilla-Vaca, A, Stone, AB, Ripolles-Melchor, J, Abad-Motos, A, Ramirez-Rodriguez, JM, Galan-Menendez, P, Mena, GE, Grant, MC, Batalla A., Azparren G., Bastitta M., Felipe M., Cueva L., Gine M., Gómez-Caro A.M., India I., Piñol S., Renedo Corcóstegui, Pablo. Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study. JOURNAL OF CLINICAL ANESTHESIA. 2021; 74DOI:10.1016/j.jclinane.2021.110378. PMID:34144497. IF:9.375(Q1/1D).
04/08/2021
Intraoperative crystalloid utilization variability and association with postoperative outcomes: A post hoc analysis of two multicenter prospective cohort studies.
Ripollés-Melchor J, Aldecoa C, Alday-Muñoz E, Del Río S, Batalla A, Del-Cojo-Peces E, Uña-Orejón R, Muñoz-Rodés JL, Lorente JV, Espinosa ÁV, Ferrando-Ortolà C, Jover JL, Abad-Gurumeta A, Ramírez-Rodríguez JM, Abad-Motos A, investigators' group of the POWER and POWER 2 studies for the Spanish Perioperat. Intraoperative crystalloid utilization variability and association with postoperative outcomes: A post hoc analysis of two multicenter prospective cohort studies.. Revista Espanola De Anestesiologia Y Reanimacion. 2021; 68(7)DOI:10.1016/j.redare.2021.07.004. PMID:34364826. IF:(Q/D).
01/01/2026
Barcelona Consensus Paper on Reconstructive Lymphedema Surgery: A Delphi Study
Masià, J, Al Sakkaf, AM, Hong, JP, Neligan, P, Pons, G, Rovnaya, A, Martínez-Jaimez, P. Barcelona Consensus Paper on Reconstructive Lymphedema Surgery: A Delphi Study. PLASTIC AND RECONSTRUCTIVE SURGERY. 2026; 157(1)DOI:10.1097/PRS.0000000000012201. PMID:40359575. IF:3.400(Q1/2D).
01/08/2025
From cadaveric donation to cryopreserved total skin allografts: Transforming the Chilean skin donation model
Fonseca, M, Cañete, A, Mandriaza, L, Gómez, J, Masiá, J, Marcelain, K, Ibaceta, D, Erazo, C, Gamez, B, Soto, C, Valdés, C. From cadaveric donation to cryopreserved total skin allografts: Transforming the Chilean skin donation model. BURNS. 2025; 51(6)DOI:10.1016/j.burns.2025.107563. PMID:40480064. IF:2.900(Q1/2D).
01/01/2025
Introduction of the 10th World Symposium for Lymphedema Surgery
Cheng, MH, Chang, DW, Masia, J. Introduction of the 10th World Symposium for Lymphedema Surgery. JOURNAL OF SURGICAL ONCOLOGY. 2025; 131(1)DOI:10.1002/jso.27919. PMID:39387585. IF:1.900(Q2/4D).
01/10/2023
Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP).
Goni-Fuste B, Pergolizzi D, Monforte-Royo C, Alonso-Babarro A, Belar A, Crespo I, Güell E, Julià-Torras J, Moreno-Alonso D, Nabal Vicuña M, Pascual A, Porta-Sales J, Rocafort J, Rodríguez-Prat A, Rodríguez D, Sala C, Serrano-Bermúdez G, Serna J, Balaguer A. Development of a Guide to Multidimensional Needs Assessment in the Palliative Care Initial Encounter (MAP).. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2023; 66(4)DOI:10.1016/j.jpainsymman.2023.07.011. PMID:37468050. IF:3.200(Q1/2D).
12/02/2024
Experimental and clinical applications and outcomes of using different forms of suction in retrograde intrarenal surgery. Results from a systematic review.
Giulioni C, Castellani D, Traxer O, Gadzhiev N, Pirola GM, Tanidir Y, da Silva RD, Glover X, Giusti G, Proietti S, Mulawkar PM, De Stefano V, Cormio A, Teoh JY, Galosi AB, Somani BK, Emiliani E, Gauhar V. Experimental and clinical applications and outcomes of using different forms of suction in retrograde intrarenal surgery. Results from a systematic review.. Actas Urologicas Espanolas. 2024; 48(1)DOI:10.1016/j.acuroe.2023.06.001. PMID:37302691. IF:(Q/D).
12/02/2024
Has fluoroless endourology (URS and PCNL) come of age? Evidence from a comprehensive literature review.
Massella V, Pietropaolo A, Gauhar V, Emiliani E, Somani BK. Has fluoroless endourology (URS and PCNL) come of age? Evidence from a comprehensive literature review.. Actas Urologicas Espanolas. 2024; 48(1)DOI:10.1016/j.acuroe.2023.06.002. PMID:37330050. IF:(Q/D).
10/12/2023
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group.
Kamat AM, Apolo AB, Babjuk M, Bivalacqua TJ, Black PC, Buckley R, Campbell MT, Compérat E, Efstathiou JA, Grivas P, Gupta S, Kurtz NJ, Lamm D, Lerner SP, Li R, McConkey DJ, Palou Redorta J, Powles T, Psutka SP, Shore N, Steinberg GD, Sylvester R, Witjes JA, Galsky MD. Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group.. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(35)DOI:10.1200/JCO.23.00307. PMID:37793077. IF:42.100(Q1/1D).
01/12/2023
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis.
Uleri A, Baboudjian M, Tedde A, Gallioli A, Long-Depaquit T, Palou J, Basile G, Gaya JM, Lughezzani G, Rajwa P, Pradere B, Roupret M, Briganti A, Ploussard G, Breda A. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis.. European Urology Oncology. 2023; 6(6)DOI:10.1016/j.euo.2023.08.001. PMID:37634971. IF:8.300(Q1/1D).
01/12/2023
Factors associated with ureteral strictures following ureteroscopy for impacted ureteral stones? A multicenter study by EAU-YAU endourology and urolithiasis working party.
Tonyali S, Pietropaolo A, Emiliani E, Ortac M, Von Bargen MF, Turan S, Glienke M, Hamid Z, Tailly T. Factors associated with ureteral strictures following ureteroscopy for impacted ureteral stones? A multicenter study by EAU-YAU endourology and urolithiasis working party.. Actas Urologicas Espanolas. 2023; 47(10)DOI:10.1016/j.acuroe.2023.04.005. PMID:37086846. IF:(Q/D).
01/11/2023
Perceptions and Practice Patterns of Urologists Relating to Intrarenal Pressure During Ureteroscopy: Findings from a Global Cross-Sectional Analysis.
Croghan SM, Somani BK, Considine SW, Breen K, McGuire BB, Manecksha RP, Gauhar V, Hameed BZ, O'Meara S, Emiliani E, Autrán Gomez AM, Agarwal D, Sener TE, O'Brien FJ, Streeper NM, Seitz C, Davis NF. Perceptions and Practice Patterns of Urologists Relating to Intrarenal Pressure During Ureteroscopy: Findings from a Global Cross-Sectional Analysis.. JOURNAL OF ENDOUROLOGY. 2023; 37(11)DOI:10.1089/end.2023.0346. PMID:37725588. IF:2.900(Q1/3D).
01/11/2023
Robotic-Assisted Repair of Ureteroenteric Strictures after Cystectomy with Urinary Diversion: Technique Description and Outcomes from the ERUS Scientific Working Group.
Rich J, Tillu N, Grauer R, Busby D, Auer R, Breda A, Buse S, D'Hondt F, Falagario UG, Hosseini A, Mehrazin R, Minervini A, Mottrie A, Sfakianos J, Palou Redorta J, Wijburg C, Wiklund NP, John H. Robotic-Assisted Repair of Ureteroenteric Strictures after Cystectomy with Urinary Diversion: Technique Description and Outcomes from the ERUS Scientific Working Group.. JOURNAL OF ENDOUROLOGY. 2023; 37(11)DOI:10.1089/end.2023.0204. PMID:37694596. IF:2.900(Q1/3D).
01/11/2023
Does gender influence retrograde intrarenal surgery (RIRS) outcomes? Data from the Flexible Ureteroscopy Outcomes Registry (FLEXOR).
Emiliani E, Sanz-Gómez I, Somani B, Tailly T, Castellani D, Traxer O, Yuen-Chun Teoh J, Chew B, Ong Lay Keat W, Chai CA, Bin-Hamri S, Shrestha A, Soehabali B, Angerri O, Gauhar V. Does gender influence retrograde intrarenal surgery (RIRS) outcomes? Data from the Flexible Ureteroscopy Outcomes Registry (FLEXOR).. Actas Urologicas Espanolas. 2023; 47(9)DOI:10.1016/j.acuroe.2023.06.008. PMID:37369300. IF:(Q/D).
01/10/2023
Open versus robotic-assisted kidney transplantation: A systematic review by the European Association of Urology (EAU) - Young Academic Urologists (YAU) Kidney Transplant Working Group.
Territo A, Bajeot AS, Mesnard B, Campi R, Pecoraro A, Hevia V, Piana A, Doumerc N, Breda A, Boissier R, Prudhomme T. Open versus robotic-assisted kidney transplantation: A systematic review by the European Association of Urology (EAU) - Young Academic Urologists (YAU) Kidney Transplant Working Group.. Actas Urologicas Espanolas. 2023; 47(8)DOI:10.1016/j.acuroe.2023.03.003. PMID:36965855. IF:(Q/D).
01/10/2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy.
Piszczek R, Krajewski W, Subiela JD, Del Giudice F, Nowak L, Chorbinska J, Moschini M, Masson-Lecomte A, Bebane S, Cimadamore A, Grobet-Jeandin E, Rouprêt M, D'Andrea D, Mastroianni R, Gutierrez Hidalgo B, Gomez Rivas J, Mori K, Soria F, Laukhtina E, Mari A, Albisinni S, Gallioli A, Mertens LS, Pichler R, Marcq G, Laszkiewicz J, Halon A, Carrion DM, Akand M, Pradere B, Shariat SF, Palou J, Babjuk M, Burgos Revilla J, Malkiewicz B, Szydelko T. Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy.. Minerva Urology And Nephrology. 2023; 75(5)DOI:10.23736/S2724-6051.23.05418-6. PMID:37728495. IF:4.900(Q1/2D).
01/10/2023
Unveiling the impact of stone disease: enhancing quality of life through comprehensive care.
Esperto F, Pietropaolo A, Emiliani E, DE Coninck V, Tailly T, Keller EX, Talso M, Tonyali S, Sener ET, Zeesha Nhameed BM, Tzelves L, Ventimiglia E, Juliebø-Jones P, Faiella E, Mykoniatis I, Tsaturyan A, Scarpa RM. Unveiling the impact of stone disease: enhancing quality of life through comprehensive care.. Minerva Urology And Nephrology. 2023; 75(5)DOI:10.23736/S2724-6051.23.05537-4. PMID:37728501. IF:4.900(Q1/2D).
01/10/2023
Comment on: "Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy".
Asero V, Scornajenghi CM, Carino D, Pandolfo SD, Krajewski W, Gallioli A, Basran S, Tresh A, Chung BI, Del Giudice F. Comment on: "Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy".. Minerva Urology And Nephrology. 2023; 75(5)DOI:10.23736/S2724-6051.23.05529-5. PMID:37530677. IF:4.900(Q1/2D).